Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amylyx Pharmaceuticals (AMLX) Return on Assets (2022 - 2025)

Historic Return on Assets for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Q3 2025 value amounting to 0.53%.

  • Amylyx Pharmaceuticals' Return on Assets rose 3600.0% to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year increase of 3600.0%. This contributed to the annual value of 0.85% for FY2024, which is 9600.0% down from last year.
  • Amylyx Pharmaceuticals' Return on Assets amounted to 0.53% in Q3 2025, which was up 3600.0% from 0.9% recorded in Q2 2025.
  • In the past 5 years, Amylyx Pharmaceuticals' Return on Assets ranged from a high of 0.1% in Q4 2023 and a low of 1.36% during Q4 2024
  • Its 4-year average for Return on Assets is 0.58%, with a median of 0.61% in 2022.
  • In the last 5 years, Amylyx Pharmaceuticals' Return on Assets skyrocketed by 9100bps in 2023 and then crashed by -14600bps in 2024.
  • Over the past 4 years, Amylyx Pharmaceuticals' Return on Assets (Quarter) stood at 0.7% in 2022, then surged by 114bps to 0.1% in 2023, then crashed by -1461bps to 1.36% in 2024, then surged by 61bps to 0.53% in 2025.
  • Its Return on Assets was 0.53% in Q3 2025, compared to 0.9% in Q2 2025 and 1.06% in Q1 2025.